Press Releases

May 25, 2021

Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier

Read More

May 19, 2021

Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection

Read More

May 18, 2021

Veracyte to Present at Upcoming Investor Conferences

Read More

May 14, 2021

Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis

Read More

May 14, 2021

Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy

Read More

May 10, 2021

Veracyte, Inc. Announces CEO Succession Plan

Read More

May 10, 2021

Veracyte Announces First Quarter 2021 Financial Results

Read More

May 04, 2021

Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress

Read More

Apr 29, 2021

Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO

Read More

Apr 27, 2021

Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis

Read More